/Copy
Some patients have continued to be sick afterward. Most patients () do not require platelet transfusions after surgery, and some patients do not require red blood cell transfusions.
There are cases of patients with indolent hematological tumors or acute leukemia in complete remission who are over 10 years old or who are not suitable for traditional treatment.
Researchers believe that the allogeneic transplant approach can be used effectively in outpatients, is less toxic and rarely requires supportive care. Another patient achieved complete remission before relapsing. The doctor said that in the future, new treatments may be used in the effective treatment of multiple myeloma, lymphoma, renal cell carcinoma and sickle cell disease.
All the patients had grafts that were viable at the beginning of transplantation, and only one patient had graft rejection ~ months after transplantation. /The median survival time of patients after treatment was days, 2 patients died from worsening of condition, 1 patient died from infection, and 1 patient died from cerebral hemorrhage.
There were cases of patients with sustained graft survival, complete remission in one case, partial remission in one case, and ineffective treatment.
Almost half of the patients develop acute graft-versus-host disease, which is effectively treated with methylprednisolone; / patients develop chronic graft-versus-host disease, and most of them respond to hormone therapy. As a result, no patients developed standard toxicities such as painful mucositis, pulmonary or cardiac toxicity, hemorrhagic cystitis, or alopecia, and some patients developed bacterial infections that required intravenous antibiotic treatment.
News